Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Market Cap	15.83B
Revenue (ttm)	2.69B
Net Income (ttm)	553.61M
Shares Out	66.47M
EPS (ttm)	8.22
PE Ratio	28.97
Forward PE	n/a
Dividend	2.50 (1.07%)
Ex-Dividend Date	Sep 6, 2024

Volume	108,606
Average Volume	185,151
Open	240.00
Previous Close	238.13
Day's Range	233.14 - 243.89
52-Week Range	130.48 - 328.04
Beta	0.15
RSI	57.81
Earnings Date	May 19, 2025

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. It serves health care professionals and government institutions. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in New Delhi, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 1,025
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: JAGSNPHARM

Financial Performance

In 2024, Jagsonpal Pharmaceuticals's revenue was 2.69 billion, an increase of 28.76% compared to the previous year's 2.09 billion. Earnings were 553.61 million, an increase of 146.45%.